Abstract
Background: Computerized physician order entry systems are known to improve patient safety in acute-care hospitals. However, as clinicians frequently override drug interaction and allergy alerts, their value in ambulatory care remains uncertain.
Objective: The purpose of the study was to examine whether ambulatory care clinicians were more likely to accept drug-drug interaction alerts that an expert panel judged to be of high clinical value.
Study Design: We convened an expert panel to examine drug-drug interaction alerts generated by 2872 clinicians in Massachusetts, Pennsylvania and New Jersey who used a common electronic prescribing system between 1 January 2006 and 30 September 2006. We selected 120 representative drug interaction alerts from the most commonly encountered class-class interactions.
Measurements: The expert panel rated each alert based on the following categories: (i) strength of the scientific evidence; (ii) probability that the interaction would result in an adverse drug event (ADE); (iii) severity of typical and most serious ADEs; (iv) the likelihood that a clinician could act on the information; and (v) the overall value of the alert to the average primary care clinician. We then used multivariate regression techniques to examine the relationship between the alert acceptance rate and the expert panel’s mean rating of each category.
Results: The decision of clinicians to accept drug interaction alerts increased (relative to a baseline alert acceptance rate of 8.8%) by 2.7% (95% CI 0.4, 5.1) for interactions that panelists judged would result in an ADE, by 2.3% (95% CI 0.9, 3.7) when primary care providers (PCPs) lacked prior knowledge about the information presented in the alert, and by 3.3% (95% CI 0.9, 5.8) when the PCP could readily act on the information provided in the alert.
Conclusion: The value of electronic drug interaction alerts is influenced heavily by clinicians’ judgements about the clinical value of the alert. Expert judgement should be taken into account when developing electronic decision support.
Similar content being viewed by others
References
Bates DW, Teich JM, Lee J, et al. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc 1999 Jul–Aug; 6(4): 313–21
Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Arch Intern Med 2003 Jun 23; 163(12): 1409–16
Weingart SN, Gandhi TK, Seger AC, et al. Patient-reported medication symptoms in primary care. Arch Intern Med 2005 Jan 24; 165(2): 234–40
Shah NR, Seger AC, Seger DL, et al. Improving acceptance of computerized prescribing alerts in ambulatory care. J Am Med Inform Assoc 2006 Jan–Feb; 13(1): 5–11
Isaac T, Weissman JS, Davis RB, et al. Overrides of medication alerts in ambulatory care. Arch Intern Med 2009 Feb 9; 169(3): 305–11
Magnus D, Rodgers S, Avery AJ. GPs’ views on computerized drug interaction alerts: questionnaire survey. J Clin Pharm Ther 2002 Oct; 27(5): 377–82
Ahearn MD, Kerr SJ. General practitioners’ perceptions of the pharmaceutical decision-support tools in their prescribing software. Med J Aust 2003 Jul 7; 179(1): 34–7
Spina JR, Glassman PA, Belperio P, et al. Clinical relevance of automated drug alerts from the perspective of medical providers. Am J Med Qual 2005 Jan–Feb; 20(1): 7–14
Ko Y, Abarca J, Malone DC, et al. Practitioners’ views on computerized drug-drug interaction alerts in the VA system. J Am Med Inform Assoc 2007 Jan–Feb; 14(1): 56–64
Lapane KL, Waring ME, Schneider KL, et al. A mixed method study of the merits of e-prescribing drug alerts in primary care. J Gen Intern Med 2008 Apr; 23(4): 442–6
Weingart SN, Toth M, Sands DZ, et al. Physicians’ decisions to override computerized drug alerts in primary care. Arch Intern Med 2003 Nov 24; 163(21): 2625–31
Vitry AI. Comparative assessment of four drug interaction compendia. Br J Clin Pharmacol 2007 Jun; 63(6): 709–14
Abarca J, Malone DC, Armstrong EP, et al. Concordance of severity ratings provided in four drug interaction compendia. J Am Pharm Assoc 2004 Mar–Apr; 44(2): 136–41
Malone DC, Abarca J, Hansten PD, et al. Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions. J Am Pharm Assoc 2004 Mar–Apr; 44(2): 142–51
Acknowledgements
This research was funded by a grant from the Physicians’ Foundation for Health Systems Excellence. The authors acknowledge Daniela Brouillard for her invaluable assistance in completing this project. The authors have no conflicts of interest to declare that are directly relevant to the content of this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Weingart, S.N., Seger, A.C., Feola, N. et al. Electronic Drug Interaction Alerts in Ambulatory Care. Drug-Safety 34, 587–593 (2011). https://doi.org/10.2165/11589360-000000000-00000
Published:
Issue Date:
DOI: https://doi.org/10.2165/11589360-000000000-00000